It is commonly seen in patients with NCI high-risk disease; however, BCR/ABL1-like ALL is also seen in patients with NCI standard-risk disease, and the outcome is associated with the MRD levels during and at the end of induction [50,51]. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.